Swiss Life Holding AG Announces Upcoming Issue of Callable Subordinated Capital Securities
Swiss Life Holding AG, through its wholly‑owned subsidiary Swiss Life Finance II AG, has publicly disclosed plans to launch an offering of callable subordinated capital securities. The proposed issuance is backed by both Swiss Life AG and Swiss Life Holding AG and will comprise a nominal aggregate principal of €600 million.
Structure and Oversight
The offering will be underwritten and managed by UBS Investment Bank. In addition, UBS Europe SE has been appointed as the stabilisation manager. The stabilisation arrangement will be active from 3 September 2026 to 9 October 2026. During this period the manager may intervene to support the market price of the securities, although such intervention is not guaranteed and may be withdrawn at any time. An over‑allotment facility of up to five percent of the nominal amount is also permitted, allowing the issuer to issue up to an additional €30 million if demand warrants.
Market Position and Investor Targeting
The disclosure explicitly addresses professional investors and high‑net‑worth individuals outside the United Kingdom. Retail investors and markets in the United States are excluded from the target audience, consistent with regulatory and jurisdictional considerations for callable subordinated capital instruments. The offering is expected to attract sophisticated capital‑market participants seeking exposure to a structured financial instrument with a call feature and subordinated priority.
Timing and Pricing
Specific details such as the offering price, interest terms, maturity date, and call schedule are yet to be finalized. Swiss Life Holding AG has committed to provide further information as the offering advances, thereby ensuring transparency and compliance with market‑making obligations.
Sectoral and Macro‑Economic Context
The decision to issue callable subordinated capital securities aligns with broader trends in the financial services sector, where insurers and asset‑management firms increasingly seek capital‑raising mechanisms that balance flexibility for issuers with risk‑adjusted returns for investors. This approach is particularly salient in an environment characterized by heightened regulatory capital requirements, low interest‑rate regimes, and a search for yield among institutional and high‑net‑worth investors.
By leveraging UBS’s expertise in structured finance and stabilisation mechanisms, Swiss Life Holding AG positions itself to capture demand from investors looking for diversified exposure to credit‑structured products. The offering also reflects the insurer’s ongoing strategy to strengthen its capital base and support long‑term sustainability in a competitive European market.
Conclusion
Swiss Life Holding AG’s forthcoming issue of callable subordinated capital securities represents a strategic initiative to enhance capital flexibility while engaging a select segment of professional and high‑net‑worth investors. With a robust support structure provided by UBS and a clear regulatory framework, the offering is poised to contribute to the broader capital‑market ecosystem that rewards disciplined risk management and strategic capital deployment.
